A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. Harrison SA, Bedossa P, Guy CD, Schattenberg JM, et al. N Engl J Med 2024;390:497-509.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Harrison SA, Bedossa P, Guy CD, Schattenberg JM, et al. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. N Engl J Med 2024;390:497-509.
PMID: 38324483